| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 322.10M | 285.50M | 273.10M | 243.20M | 189.30M |
| Gross Profit | 137.40M | 65.50M | 124.30M | 101.00M | 74.20M |
| EBITDA | 120.50M | 86.20M | 88.10M | 72.70M | 51.50M |
| Net Income | 33.10M | 29.60M | 30.80M | 30.50M | 24.90M |
Balance Sheet | |||||
| Total Assets | 689.10M | 655.80M | 492.30M | 511.60M | 459.60M |
| Cash, Cash Equivalents and Short-Term Investments | 51.10M | 50.50M | 19.80M | 34.00M | 22.60M |
| Total Debt | 189.80M | 67.50M | 289.40M | 313.60M | 233.60M |
| Total Liabilities | 363.10M | 234.90M | 434.50M | 463.30M | 353.30M |
| Stockholders Equity | 303.60M | 403.80M | 57.80M | 48.30M | 106.30M |
Cash Flow | |||||
| Free Cash Flow | 45.30M | 43.80M | 61.60M | 59.20M | 50.70M |
| Operating Cash Flow | 47.90M | 45.50M | 65.80M | 61.90M | 52.00M |
| Investing Cash Flow | -34.10M | -75.90M | -4.20M | -35.40M | -97.50M |
| Financing Cash Flow | -11.70M | 60.50M | -74.50M | -14.80M | 50.90M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
77 Outperform | £221.14M | 10.47 | 6.46% | 3.68% | 2.11% | 818.58% | |
76 Outperform | £375.30M | 19.98 | 14.71% | 2.13% | 34.36% | 17.53% | |
75 Outperform | £24.60B | 15.26 | 26.35% | 1.40% | 5.83% | 11.65% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
63 Neutral | £773.78M | 24.99 | 9.94% | 1.19% | 12.82% | 16.40% | |
60 Neutral | £346.85M | -3.42 | -12.22% | 15.28% | -3.91% | -310.36% | |
54 Neutral | £359.73M | 275.23 | 0.58% | 2.31% | 10.68% | -89.58% |